219 related articles for article (PubMed ID: 8309643)
1. Action myoclonus after cerebral anoxia.
Rizvi AH; Karetzky MS
N J Med; 1993 Dec; 90(12):918-20. PubMed ID: 8309643
[TBL] [Abstract][Full Text] [Related]
2. Interictal myoclonus with paroxysmal kinesigenic dyskinesia.
Cochen De Cock V; Bourdain F; Apartis E; Trocello JM; Roze E; Vidailhet M
Mov Disord; 2006 Sep; 21(9):1533-5. PubMed ID: 16763976
[TBL] [Abstract][Full Text] [Related]
3. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences.
Goetz CG; Vu TQ; Carvey PM; Leurgans S
Mov Disord; 2000; 15 Suppl 1():39-46. PubMed ID: 10755271
[No Abstract] [Full Text] [Related]
4. Animal models of posthypoxic myoclonus: I. Development and validation.
Truong DD; Kanthasamy A; Nguyen B; Matsumoto R; Schwartz P
Mov Disord; 2000; 15 Suppl 1():26-30. PubMed ID: 10755269
[No Abstract] [Full Text] [Related]
5. Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes.
Lance JW
Adv Neurol; 1986; 43():33-55. PubMed ID: 3080851
[TBL] [Abstract][Full Text] [Related]
6. Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization.
Kanthasamy AG; Nguyen BQ; Truong DD
Mov Disord; 2000; 15 Suppl 1():31-8. PubMed ID: 10755270
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
[TBL] [Abstract][Full Text] [Related]
8. Physiology of human posthypoxic myoclonus.
Hallett M
Mov Disord; 2000; 15 Suppl 1():8-13. PubMed ID: 10755266
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of piracetam in cortical myoclonus.
Brown P; Steiger MJ; Thompson PD; Rothwell JC; Day BL; Salama M; Waegemans T; Marsden CD
Mov Disord; 1993; 8(1):63-8. PubMed ID: 8419809
[TBL] [Abstract][Full Text] [Related]
10. The clinical features and prognosis of chronic posthypoxic myoclonus.
Werhahn KJ; Brown P; Thompson PD; Marsden CD
Mov Disord; 1997 Mar; 12(2):216-20. PubMed ID: 9087980
[TBL] [Abstract][Full Text] [Related]
11. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management.
Rubboli G; Tassinari CA
Neurophysiol Clin; 2006; 36(5-6):337-43. PubMed ID: 17336779
[TBL] [Abstract][Full Text] [Related]
12. Eyelid myoclonia and absence.
Covanis A
Adv Neurol; 2005; 95():185-96. PubMed ID: 15508923
[No Abstract] [Full Text] [Related]
13. A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus.
Brown P; Thompson PD; Rothwell JC; Day BL; Marsden CD
Mov Disord; 1991; 6(2):139-44. PubMed ID: 1905387
[TBL] [Abstract][Full Text] [Related]
14. High-frequency rhythmic cortical myoclonus in a long-surviving patient with nonketotic hypergylcemia.
Mastrangelo M; Canafoglia L; Franceschetti S; Oppezzo C; Mosca F; Menni F; Parini R; Ciano C; Scaioli V; Panzica F
J Child Neurol; 2008 Mar; 23(3):321-4. PubMed ID: 18182648
[TBL] [Abstract][Full Text] [Related]
15. Novel rat cardiac arrest model of posthypoxic myoclonus.
Truong DD; Matsumoto RR; Schwartz PH; Hussong MJ; Wasterlain CG
Mov Disord; 1994 Mar; 9(2):201-6. PubMed ID: 8196684
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiogical and neuropharmacological studies in a patient with progressive myoclonus-epilepsy (author's transl)].
Rumpl E; Gerstenbrand F; Hengl W; Binder H
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1977 Jun; 8(2):77-81. PubMed ID: 408123
[TBL] [Abstract][Full Text] [Related]
17. The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity.
Welsh JP; Placantonakis DG; Warsetsky SI; Marquez RG; Bernstein L; Aicher SA
Adv Neurol; 2002; 89():307-29. PubMed ID: 11968457
[TBL] [Abstract][Full Text] [Related]
18. Involvement of GABA(A) receptors in myoclonus.
Matsumoto RR; Truong DD; Nguyen KD; Dang AT; Hoang TT; Vo PQ; Sandroni P
Mov Disord; 2000; 15 Suppl 1():47-52. PubMed ID: 10755272
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
[TBL] [Abstract][Full Text] [Related]
20. Animal models of myoclonus: an overview.
Nguyen BQ; Kanthasamy AG; Truong DD
Mov Disord; 2000; 15 Suppl 1():22-5. PubMed ID: 10755268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
